151 related articles for article (PubMed ID: 7950898)
1. 13-cis-retinoic acid, beta-carotene and other anti-oxidant agents in chemoprevention and therapy of head and neck cancer.
Toma S; Palumbo R; Raffo P; Spadini N; Rosso R
Eur J Cancer Prev; 1994 Jul; 3(4):374-7. PubMed ID: 7950898
[No Abstract] [Full Text] [Related]
2. Biologic modifiers and chemoprevention of cancer of the oral cavity.
Richtsmeier WJ
N Engl J Med; 1993 Jan; 328(1):58-9. PubMed ID: 8416272
[No Abstract] [Full Text] [Related]
3. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis.
Lippman SM; Batsakis JG; Toth BB; Weber RS; Lee JJ; Martin JW; Hays GL; Goepfert H; Hong WK
N Engl J Med; 1993 Jan; 328(1):15-20. PubMed ID: 8416267
[TBL] [Abstract][Full Text] [Related]
4. Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up.
Papadimitrakopoulou VA; Hong WK; Lee JS; Martin JW; Lee JJ; Batsakis JG; Lippman SM
J Natl Cancer Inst; 1997 Feb; 89(3):257-8. PubMed ID: 9017007
[No Abstract] [Full Text] [Related]
5. A population-based trial of beta-carotene chemoprevention of head and neck cancer.
Mayne ST; Zheng T; Janerich DT; Goodwin WJ; Fallon BG; Cooper DL; Friedman CD
Adv Exp Med Biol; 1992; 320():119-27. PubMed ID: 1442276
[No Abstract] [Full Text] [Related]
6. Chemoprevention strategies in lung carcinogenesis.
Lippman SM; Benner SE; Hong WK
Chest; 1993 Jan; 103(1 Suppl):15S-19S. PubMed ID: 8416769
[TBL] [Abstract][Full Text] [Related]
7. Results, toxicity and compliance in chemoprevention trials of head and neck cancer.
Toma S; Palumbo R; Rosso R
Eur J Cancer Prev; 1994 Jan; 3(1):63-8. PubMed ID: 8130719
[TBL] [Abstract][Full Text] [Related]
8. Current status of chemoprevention of head and neck cancer.
Benner SE; Lippman SM; Hong WK
Oncology (Williston Park); 1992 Aug; 6(8):61-6; discussion 66-8, 71 passim. PubMed ID: 1386997
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention in head and neck cancer.
Mellott A; Vokes E
Cancer Treat Res; 2001; 106():221-35. PubMed ID: 11225004
[No Abstract] [Full Text] [Related]
10. Chemoprevention of oral squamous cell carcinomas.
Scheer M; Kuebler AC; Zöller JE
Onkologie; 2004 Apr; 27(2):187-93. PubMed ID: 15138354
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of aerodigestive epithelial cancers.
Lippman SM; Hong WK
Adv Exp Med Biol; 1992; 320():151-61. PubMed ID: 1442280
[No Abstract] [Full Text] [Related]
12. Carotenoid intake and head and neck cancer: a pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
Leoncini E; Edefonti V; Hashibe M; Parpinel M; Cadoni G; Ferraroni M; Serraino D; Matsuo K; Olshan AF; Zevallos JP; Winn DM; Moysich K; Zhang ZF; Morgenstern H; Levi F; Kelsey K; McClean M; Bosetti C; Schantz S; Yu GP; Boffetta P; Lee YC; Chuang SC; Decarli A; La Vecchia C; Boccia S
Eur J Epidemiol; 2016 Apr; 31(4):369-83. PubMed ID: 25930054
[TBL] [Abstract][Full Text] [Related]
13. 13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group.
Toma S; Bonelli L; Sartoris A; Mira E; Antonelli A; Beatrice F; Giordano C; Benazzo M; Caroggio A; Cavalot AL; Gandolfo S; Garozzo A; Margarino G; Schenone G; Spadini N; Sirotovà Z; Zibordi F; Balzarini F; Serafini I; Miani P; Cortesina G
Oncol Rep; 2004 Jun; 11(6):1297-305. PubMed ID: 15138569
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.
Mayne ST; Cartmel B; Baum M; Shor-Posner G; Fallon BG; Briskin K; Bean J; Zheng T; Cooper D; Friedman C; Goodwin WJ
Cancer Res; 2001 Feb; 61(4):1457-63. PubMed ID: 11245451
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy.
Cascinu S; Del Ferro E; Ligi M; Graziano F; Castellani A; Catalano G
Ann Oncol; 1996 Jul; 7(5):538. PubMed ID: 8839916
[No Abstract] [Full Text] [Related]
16. Isotretinoin for prevention of second primary squamous cell carcinoma of the head and neck.
Briggs RJ; Forastiere AA
Otolaryngol Head Neck Surg; 1991 Nov; 105(5):752-4. PubMed ID: 1754264
[No Abstract] [Full Text] [Related]
17. Chemoprevention of head and neck cancer: an update.
Papadimitrakopoulou VA
Curr Opin Oncol; 2002 May; 14(3):318-22. PubMed ID: 11981278
[TBL] [Abstract][Full Text] [Related]
18. [Chemoprevention of (pre)malignant disorders of the head and neck area. Current situation].
de Vries N; Snow GB
Ned Tijdschr Tandheelkd; 1994 Mar; 101(3):93-4; quiz 95, 110. PubMed ID: 11830958
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
[TBL] [Abstract][Full Text] [Related]
20. 13-cis retinoic acid and interferon-alpha +/- irradiation in the treatment of squamous-cell carcinomas.
Hoffmann W; Schiebe M; Hirnle P; Souchon R; Clemens M; Adamietz I; Bamberg M
Int J Cancer; 1997 Feb; 70(4):475-7. PubMed ID: 9033659
[No Abstract] [Full Text] [Related]
[Next] [New Search]
